Numerous client proteins of HSP90 have been identified in known cardiac disease pathways, including MAPK signaling, PI3K/AKT (PKB)/mTOR, and TNF-α signaling, all of which are direct and indirect targets of HSP90. This evidence concerns the gene AKT1 and heart disorder.